SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31)
SALIX PHARMACEUTICALS LTD reported Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) of $33.80 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense · last filed 2012-02-28
- SALIX PHARMACEUTICALS LTD finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2011 was $33.80M, a 0.00% change from fiscal 2010.
- SALIX PHARMACEUTICALS LTD finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2010 was $33.80M.
| Period end | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $33.80M 10-K · filed 2012-02-28 |
| 2010-12-31 | $33.80M 10-K · filed 2012-02-28 |